Business Description
Enzolytics Inc
NAICS : 325412
SIC : 2834
ISIN : US2941121079
Compare
Compare
Traded in other countries / regions
ENZC.USA IPO Date
2008-07-15Description
Enzolytics Inc is a drug development company committed to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. The company is committed to creating drugs for the good health of mankind. ENZC's flagship compound, ITV-1, is a suspension of Inactivated Pepsin Fragment (IPF), which studies have shown is effective in the treatment of HIV. IPF is the active drug substance of ITV-1 and is a purified extract of porcine pepsin. ITV-1 has been shown to modulate the immune system. IPF is a platform technology that can be used to facilitate a broad range of applications. It is free from neurological, gastrointestinal and hematological side effects seen in the anti-retrovirals in use.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 52.12 | |||||
9-Day RSI | 56.68 | |||||
14-Day RSI | 58.21 | |||||
3-1 Month Momentum % | 133.33 | |||||
6-1 Month Momentum % | 133.33 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
FCF Margin % | -758.7 | |||||
OCF Margin % | -758.7 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-EBIT | -0.67 | |||||
EV-to-EBITDA | -0.68 | |||||
EV-to-Revenue | 94.52 | |||||
EV-to-FCF | -12.46 | |||||
Earnings Yield (Greenblatt) % | -149.25 | |||||
FCF Yield % | -8.03 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:ENZC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Enzolytics Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.046 | ||
| EPS (TTM) ($) | -170.268 | ||
| Beta | 1.3227 | ||
| 3-Year Sharpe Ratio | -0.78 | ||
| 3-Year Sortino Ratio | -1.1 | ||
| Volatility % | 151.3 | ||
| 14-Day RSI | 58.21 | ||
| 14-Day ATR ($) | 0.000189 | ||
| 20-Day SMA ($) | 0.000948 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 0.0002 - 0.0013 | ||
| Shares Outstanding (Mil) | 4,831.06 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Enzolytics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Enzolytics Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-19 | In 142 days | ||
| Second quarter earnings results for 2026 | 2026-08-20 | In 51 days | ||
| General meeting for 2025 | 2026-06-29 | 0.00 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-06-12 | 0.00 (+0.00%) | ||
| Annual report for 2025 | 2026-04-16 | 0.00 (+33.33%) | ||
| Third quarter earnings results for 2025 | 2025-11-19 | 0.00 (+0.00%) | ||
| Second quarter earnings results for 2025 | 2025-08-20 | 0.00 (+0.00%) | ||
| First quarter earnings results for 2025 | 2025-05-23 | 0.00 (+0.00%) | ||
| Annual report for 2024 | 2025-05-16 | 0.00 (-10.00%) | ||
| Third quarter earnings results for 2024 | 2024-10-18 | 0.00 (+6.25%) |
Show
Entries
Enzolytics Inc Frequently Asked Questions
What is Enzolytics Inc(ENZC)'s stock price today?
The current price of ENZC is $0.00. The 52 week high of ENZC is $0.00 and 52 week low is $0.00.
When is next earnings date of Enzolytics Inc(ENZC)?
The next earnings date of Enzolytics Inc(ENZC) is 2026-08-20 Est..
Does Enzolytics Inc(ENZC) pay dividends? If so, how much?
Enzolytics Inc(ENZC) does not pay dividend.
Guru Commentaries on OTCPK:ENZC
No articles.
Press Release
Articles on Enzolytics Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers